Travere Therapeutics, Inc. (NASDAQ:TVTX) appears in 270 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Janus Henderson Group Plc | 31 Mar, 2026 | 22,839,172 | 12,328,006 | 117.28% | $678,493,230.00 |
| FMR LLC | 31 Mar, 2026 | 10,967,967 | 1,350,104 | 14.04% | $325,858,279.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 7,792,033 | -77,319 | -0.98% | $231,501,299.00 |
| State Street Corp | 31 Mar, 2026 | 4,959,988 | 203,322 | 4.27% | $147,361,243.00 |
| ARMISTICE CAPITAL, LLC | 31 Mar, 2026 | 4,897,417 | 1,133,526 | 30.12% | $145,502,259.00 |
| PERCEPTIVE ADVISORS LLC | 31 Mar, 2026 | 4,142,551 | -135,629 | -3.17% | $123,075,190.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 4,045,812 | 4,045,812 | 0.00% | $120,201,075.00 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 31 Mar, 2026 | 3,270,513 | -503,051 | -13.33% | $97,167,000.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 2,369,559 | 226,064 | 10.55% | $70,411,435.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 1,966,779 | -280,000 | -12.46% | $58,433,004.00 |
| Stephens Investment Management Group LLC | 31 Mar, 2026 | 1,798,466 | 76,843 | 4.46% | $53,432,425.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 1,719,721 | -2,016,703 | -53.97% | $51,092,910.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 1,709,139 | 1,709,139 | 0.00% | $50,778,520.00 |
| Kynam Capital Management, LP | 31 Mar, 2026 | 1,569,018 | 1,051,134 | 202.97% | $46,615,525.00 |
| EMERALD ADVISERS, LLC | 31 Mar, 2026 | 1,557,196 | -36,988 | -2.32% | $46,264,293.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Mar, 2026 | 1,508,259 | 351,452 | 30.38% | $44,810,375.00 |
| Rock Springs Capital Management LP | 31 Mar, 2026 | 1,477,954 | -732,368 | -33.13% | $43,910,013.00 |
| Bank Of America Corp /De/ | 31 Mar, 2026 | 1,345,111 | -505,244 | -27.31% | $39,963,238.00 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 1,282,518 | 381,114 | 42.28% | $38,103,610.00 |
| MPM BioImpact LLC | 31 Mar, 2026 | 1,133,365 | 1,133,365 | 0.00% | $33,672,274.00 |